Search Results

You are looking at 81 - 90 of 1,092 items for :

  • "NCCN Guidelines" x
Clear All
Full access

Peter H. Carroll and James L. Mohler

Family Comprehensive Cancer Center, speaking at the NCCN 23rd Annual Conference. Dr. Carroll, Chair of the NCCN Guidelines for Prostate Cancer Early Detection, reviewed updates to the 2018 guidelines. Screening/early detection guidelines for prostate

Full access

NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019

Featured Updates to the NCCN Guidelines

Andrew D. Zelenetz, Leo I. Gordon, Jeremy S. Abramson, Ranjana H. Advani, Nancy L. Bartlett, Paolo F. Caimi, Julie E. Chang, Julio C. Chavez, Beth Christian, Luis E. Fayad, Martha J. Glenn, Thomas M. Habermann, Nancy Lee Harris, Francisco Hernandez-Ilizaliturri, Mark S. Kaminski, Christopher R. Kelsey, Nadia Khan, Susan Krivacic, Ann S. LaCasce, Amitkumar Mehta, Auayporn Nademanee, Rachel Rabinovitch, Nishitha Reddy, Erin Reid, Kenneth B. Roberts, Stephen D. Smith, Erin D. Snyder, Lode J. Swinnen, Julie M. Vose, Mary A. Dwyer and Hema Sundar

to: Integrate into professional practice the updates to the NCCN Guidelines for B-Cell Lymphomas Describe the rationale behind the decision-making process for developing the NCCN Guidelines for B-Cell Lymphomas Disclosure of Relevant Financial

Full access

Patrick A. Brown, Matthew Wieduwilt, Aaron Logan, Daniel J. DeAngelo, Eunice S. Wang, Amir Fathi, Ryan D. Cassaday, Mark Litzow, Anjali Advani, Patricia Aoun, Bhavana Bhatnagar, Michael W. Boyer, Teresa Bryan, Patrick W. Burke, Peter F. Coccia, Steven E. Coutre, Nitin Jain, Suzanne Kirby, Arthur Liu, Stephanie Massaro, Ryan J. Mattison, Olalekan Oluwole, Nikolaos Papadantonakis, Jae Park, Jeffrey E. Rubnitz, Geoffrey L. Uy, Kristina M. Gregory, Ndiya Ogba and Bijal Shah

to: Integrate updates to the NCCN Guidelines for Acute Lymphoblastic Leukemia into the management of older adult patients with acute lymphoblastic leukemia Describe the rationale behind the decision-making process for developing the NCCN Guidelines

Full access

Andrew D. Zelenetz, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C. Byrd, Myron S. Czuczman, Luis E. Fayad, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Christopher R. Kelsey, Youn H. Kim, Ann S. LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nashitha Reddy, Lubomir Sokol, Lode J. Swinnen, Christina Tsien, Julie M. Vose, William G. Wierda, Joachim Yahalom and Nadeem Zafar

2 decades. 2 As a result, patients with NHL may also have significant comorbid conditions, which complicate treatment options. NOTE: This manuscript highlights only a portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines

Full access

Kilian E. Salerno

In the most recent NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer, there were updates pertaining to various radiation treatment options, including whole-breast radiotherapy (RT), accelerated partial

Full access

Arnel Pallera, Jessica K. Altman, Ellin Berman, Camille N. Abboud, Bhavana Bhatnagar, Peter Curtin, Daniel J. DeAngelo, Jason Gotlib, R. Tanner Hagelstrom, Gabriela Hobbs, Madan Jagasia, Hagop M. Kantarjian, Patricia Kropf, Leland Metheny, Joseph O. Moore, Evelena Ontiveros, Enkhtsetseg Purev, Albert Quiery, Vishnu V.B. Reddy, Michal G. Rose, Neil P. Shah, B. Douglas Smith, David S. Snyder, Kendra L. Sweet, Raoul Tibes, David T. Yang, Kristina Gregory, Hema Sundar, Michael Deininger and Jerald P. Radich

this activity, participants will be able to: Integrate into professional practice the updates to NCCN Guidelines for Chronic Myeloid Leukemia Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Chronic

Full access

NCCN Guidelines Insights: Breast Cancer, Version 3.2018

Featured Updates to the NCCN Guidelines

Matthew P. Goetz, William J. Gradishar, Benjamin O. Anderson, Jame Abraham, Rebecca Aft, Kimberly H. Allison, Sarah L. Blair, Harold J. Burstein, Chau Dang, Anthony D. Elias, William B. Farrar, Sharon H. Giordano, Lori J. Goldstein, Steven J. Isakoff, Janice Lyons, P. Kelly Marcom, Ingrid A. Mayer, Meena S. Moran, Joanne Mortimer, Ruth M. O'Regan, Sameer A. Patel, Lori J. Pierce, Elizabeth C. Reed, Hope S. Rugo, Amy Sitapati, Karen Lisa Smith, Mary Lou Smith, Hatem Soliman, Melinda L. Telli, John H. Ward, Jessica S. Young, Dorothy A. Shead and Rashmi Kumar

be able to: Integrate into professional practice the updates to the NCCN Guidelines for Breast Cancer Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Breast Cancer Disclosure of Relevant Financial

Full access

Eric Jonasch

Panel Revises Risk Categories, Anticipates New Drug Approvals An important update to the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Kidney Cancer was the revision of risk classifications, a result of some clinical trials

Full access

Peter G. Shields

done in the clinic in just a few minutes,” Dr. Shields said. The goals of the new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Smoking Cessation are to establish standards of care, facilitate implementation with clear guidelines

Full access

John A. Thompson

, University of Washington; Co-Director, Melanoma Clinic, Seattle Cancer Care Alliance; and Chair of the NCCN Guidelines Panel for Management of Immunotherapy-Related Toxicities. NCCN in collaboration with ASCO developed a standardized approach for the